Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Semaglutide 2.4mg (GLP-1 Agonist): Proven GLP-1 effects (appetite suppression, gastric emptying) Already FDA-approved as Wegovy Established safety profile Cagrilintide 2.4mg (Amylin Analog): Mimics amylin, a hormone co-secreted with insulin Slows gastric emptying through different pathway than GLP-1 Reduces appetite through hindbrain (not hypothalamus) Improves postprandial glucose The Advantage: Leverages proven semaglutide efficacy and safety, adds complementary amylin effects
doi:10.2174/1381612826666200424180139 Park JM, Lee HJ, Sikiric P, Hahm KB
Because I know a number of people are sort of getting drawn back to intermittent fasting after a couple of years of it getting beat up on like, Its not the best way to lose fat. I think its a terrific way to do the sorts of things that youre describing, and Im learning today more about the positive things it can do for insulin sensitivity and so forth
When paired with BPC-157, its anti-inflammatory properties become evident as well
US$ 23.63
US$ 25.38
US$ 21.44
